Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Advantra Z is a standardized, clinically studied extract of Citrus aurantium (bitter orange), primarily containing the protoalkaloid p-synephrine as its main active component. It is used as a dietary supplement ingredient for weight management, sports nutrition, and energy enhancement. The mechanism of action involves stimulation of beta-3 adrenergic receptors in adipose tissue and muscle, promoting thermogenesis (increased heat production) and lipolysis (breakdown of fat), which can increase resting metabolic rate and support fat loss. Unlike other stimulants such as ephedrine, Advantra Z has minimal impact on cardiovascular parameters like heart rate or blood pressure due to its selectivity for beta-3 over other adrenergic receptors. Multiple clinical studies have demonstrated its safety profile at recommended doses[1][2][4][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Advantra Z.